CNCE logo

Concert Pharmaceuticals (CNCE) Depreciation And Amortization

Annual D&A

$1.48 M
-$126.00 K-7.85%

31 December 2021

3-Year Change

-7.85%
CNCE annual depreciation & amortization is down -7.85% over the past 3 years

All-time High

$1.66 M
CNCE annual depreciation & amortization is currently -11.12% below its historical high of $1.66 million
Annual Total Expenses$110.09 M
CNCE annual total expenses is $110.09 million
Annual Operating Expenses$110.09 M
CNCE annual total operating expenses is $110.09 million
Annual Revenue$32.58 M
CNCE annual revenue is $32.58 million
Annual Net Income-$80.05 M
CNCE annual net profit is -$80.05 million

CNCE Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$303.00 K
-$14.00 K-4.42%

30 September 2022

3-Year Change

-17.66%
CNCE quarterly depreciation & amortization is down -17.66% over the past 3 years

All-time High

$444.00 K
CNCE quarterly depreciation & amortization is currently -31.76% below its historical high of $444.00 thousand
Quarterly Total Expenses$29.61 M
CNCE quarterly total expenses is $29.61 million
Quarterly Operating Expenses$29.61 M
CNCE quarterly total operating expenses is $29.61 million
Quarterly Revenue$8000.00
CNCE quarterly revenue is $8000.00
Quarterly Net Income-$28.90 M
CNCE quarterly net profit is -$28.90 million

CNCE Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$1.27 M
-$65.00 K-4.88%

30 September 2022

3-Year Change

-18.26%
CNCE TTM depreciation & amortization is down -18.26% over the past 3 years

All-time High

$1.66 M
CNCE TTM depreciation & amortization is currently -23.86% below its historical high of $1.66 million
Annual Total Expenses$110.09 M
CNCE annual total expenses is $110.09 million
Annual Operating Expenses$110.09 M
CNCE annual total operating expenses is $110.09 million
TTM Revenue$42.00 K
CNCE TTM revenue is $42.00 thousand
TTM Net Income-$126.31 M
CNCE TTM net profit is -$126.31 million

CNCE TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CNCE Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years-7.8%-17.7%-18.3%
5 y5 years+18.6%-25.6%-22.2%

CNCE Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-11.1%-31.8%-23.9%

Concert Pharmaceuticals Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2022
-
$303.00 K(-4.4%)
$1.27 M(-4.9%)
June 2022
-
$317.00 K(-1.2%)
$1.33 M(-5.4%)
Mar 2022
-
$321.00 K(-1.5%)
$1.41 M(-4.8%)
Dec 2021
$1.48 M(-7.9%)
$326.00 K(-11.4%)
$1.48 M(-4.6%)
Sept 2021
-
$368.00 K(-6.4%)
$1.55 M(-2.2%)
June 2021
-
$393.00 K(+0.3%)
$1.58 M(-0.3%)
Mar 2021
-
$392.00 K(-1.3%)
$1.59 M(-1.0%)
Dec 2020
$1.60 M(-3.5%)
$397.00 K(-1.5%)
$1.60 M(-0.7%)
Sept 2020
-
$403.00 K(+1.5%)
$1.62 M(-0.2%)
June 2020
-
$397.00 K(-2.7%)
$1.62 M(-0.5%)
Mar 2020
-
$408.00 K(0.0%)
$1.63 M(-2.2%)
Dec 2019
$1.66 M(+33.4%)
$408.00 K(+0.2%)
$1.66 M(+2.2%)
Sept 2019
-
$407.00 K(+0.5%)
$1.63 M(+2.6%)
June 2019
-
$405.00 K(-8.8%)
$1.59 M(+10.4%)
Mar 2019
-
$444.00 K(+19.4%)
$1.44 M(+15.3%)
Dec 2018
$1.25 M(+23.7%)
$372.00 K(+1.6%)
$1.25 M(+10.0%)
Sept 2018
-
$366.00 K(+43.0%)
$1.13 M(+10.7%)
June 2018
-
$256.00 K(+1.2%)
$1.02 M(+1.1%)
Mar 2018
-
$253.00 K(-2.3%)
$1.01 M(+0.5%)
Dec 2017
$1.01 M
$259.00 K(+1.2%)
$1.01 M(+2.1%)
DateAnnualQuarterlyTTM
Sept 2017
-
$256.00 K(+4.5%)
$987.00 K(+3.2%)
June 2017
-
$245.00 K(-1.2%)
$956.00 K(+2.7%)
Mar 2017
-
$248.00 K(+4.2%)
$931.00 K(+4.3%)
Dec 2016
$893.00 K(+13.8%)
$238.00 K(+5.8%)
$893.00 K(+3.5%)
Sept 2016
-
$225.00 K(+2.3%)
$863.00 K(+1.9%)
June 2016
-
$220.00 K(+4.8%)
$847.00 K(+4.3%)
Mar 2016
-
$210.00 K(+1.0%)
$812.00 K(+3.4%)
Dec 2015
$785.00 K(-25.4%)
$208.00 K(-0.5%)
$785.00 K(+21.3%)
Sept 2015
-
$209.00 K(+13.0%)
$647.00 K(-16.0%)
June 2015
-
$185.00 K(+1.1%)
$770.00 K(-15.3%)
Mar 2015
-
$183.00 K(+161.4%)
$909.00 K(-13.6%)
Dec 2014
$1.05 M(-21.8%)
$70.00 K(-78.9%)
$1.05 M(-20.4%)
Sept 2014
-
$332.00 K(+2.5%)
$1.32 M(-0.2%)
June 2014
-
$324.00 K(-0.6%)
$1.32 M(-0.7%)
Mar 2014
-
$326.00 K(-4.1%)
$1.33 M(-0.9%)
Dec 2013
$1.35 M(-7.3%)
$340.00 K(+1.8%)
$1.35 M(+33.8%)
Sept 2013
-
$334.00 K(0.0%)
$1.01 M(+49.7%)
June 2013
-
$334.00 K(-1.2%)
$672.00 K(+98.8%)
Mar 2013
-
$338.00 K
$338.00 K
Dec 2012
$1.45 M(-10.3%)
-
-
Dec 2011
$1.62 M
-
-

FAQ

  • What is Concert Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Concert Pharmaceuticals?
  • What is Concert Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Concert Pharmaceuticals?
  • What is Concert Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Concert Pharmaceuticals?

What is Concert Pharmaceuticals annual depreciation & amortization?

The current annual D&A of CNCE is $1.48 M

What is the all time high annual D&A for Concert Pharmaceuticals?

Concert Pharmaceuticals all-time high annual depreciation & amortization is $1.66 M

What is Concert Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of CNCE is $303.00 K

What is the all time high quarterly D&A for Concert Pharmaceuticals?

Concert Pharmaceuticals all-time high quarterly depreciation & amortization is $444.00 K

What is Concert Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of CNCE is $1.27 M

What is the all time high TTM D&A for Concert Pharmaceuticals?

Concert Pharmaceuticals all-time high TTM depreciation & amortization is $1.66 M